So when can we expect some Canadian drugs?

Yesterday, the Trump administration unveiled a plan that would allow Americans to import some drugs from Canada, where medicines tend to be considerably cheaper.

That sounds simple enough, but, as STAT’s Nicholas Florko explains, the details are infinitely more complex.

For one, the plan doesn’t cover biologics, which tend to be the most expensive treatments on the market; it doesn’t allow individuals to order therapies from across the border; and it might take years before even a pilot program takes effect.

Read more.